Skip to main content
. 2018 Jul 27;97(30):e11647. doi: 10.1097/MD.0000000000011647

Figure 1.

Figure 1

(A) Recurrence-free survival curve and (B) overall survival curve according to hormone receptor (HR) and lymphovascular invasion (LVI) (P < .001 and P < .001, respectively).